Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Statistics

Total Valuation

KRX:249420 has a market cap or net worth of KRW 670.16 billion. The enterprise value is 813.94 billion.

Market Cap	670.16B
Enterprise Value	813.94B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:249420 has 30.88 million shares outstanding. The number of shares has increased by 1.19% in one year.

Current Share Class	30.88M
Shares Outstanding	30.88M
Shares Change (YoY)	+1.19%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	2.72%
Float	19.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	4.00
P/TBV Ratio	4.91
P/FCF Ratio	101.13
P/OCF Ratio	41.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.40, with an EV/FCF ratio of 122.82.

EV / Earnings	-328.01
EV / Sales	1.39
EV / EBITDA	20.40
EV / EBIT	53.05
EV / FCF	122.82

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.24.

Current Ratio	0.79
Quick Ratio	0.40
Debt / Equity	1.24
Debt / EBITDA	5.18
Debt / FCF	31.40
Interest Coverage	1.02

Financial Efficiency

Return on equity (ROE) is -5.73% and return on invested capital (ROIC) is 2.55%.

Return on Equity (ROE)	-5.73%
Return on Assets (ROA)	1.64%
Return on Invested Capital (ROIC)	2.55%
Return on Capital Employed (ROCE)	5.67%
Revenue Per Employee	549.34M
Profits Per Employee	-2.33M
Employee Count	1,067
Asset Turnover	0.99
Inventory Turnover	3.80

Taxes

Income Tax	-4.20B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +65.32% in the last 52 weeks. The beta is 1.14, so KRX:249420's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	+65.32%
50-Day Moving Average	20,453.40
200-Day Moving Average	13,911.10
Relative Strength Index (RSI)	48.23
Average Volume (20 Days)	1,392,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:249420 had revenue of KRW 586.15 billion and -2.48 billion in losses. Loss per share was -88.84.

Revenue	586.15B
Gross Profit	221.37B
Operating Income	15.59B
Pretax Income	-13.92B
Net Income	-2.48B
EBITDA	40.15B
EBIT	15.59B
Loss Per Share	-88.84

Balance Sheet

The company has 68.54 billion in cash and 208.09 billion in debt, giving a net cash position of -139.55 billion or -4,518.70 per share.

Cash & Cash Equivalents	68.54B
Total Debt	208.09B
Net Cash	-139.55B
Net Cash Per Share	-4,518.70
Equity (Book Value)	167.44B
Book Value Per Share	5,843.09
Working Capital	-64.98B

Cash Flow

In the last 12 months, operating cash flow was 16.23 billion and capital expenditures -9.61 billion, giving a free cash flow of 6.63 billion.

Operating Cash Flow	16.23B
Capital Expenditures	-9.61B
Free Cash Flow	6.63B
FCF Per Share	214.59

Margins

Gross margin is 37.77%, with operating and profit margins of 2.66% and -0.42%.

Gross Margin	37.77%
Operating Margin	2.66%
Pretax Margin	-2.37%
Profit Margin	-0.42%
EBITDA Margin	6.85%
EBIT Margin	2.66%
FCF Margin	1.13%

Dividends & Yields

KRX:249420 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.19%
Shareholder Yield	n/a
Earnings Yield	-0.37%
FCF Yield	0.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Mar 5, 2020
Split Type	Forward
Split Ratio	1.05

Scores

KRX:249420 has an Altman Z-Score of 1.63 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.63
Piotroski F-Score	6